Re:NIH Scientists Identify Antibody That Neutralizes Nearly ...
by ars on Saturday November 19, 2016 @11:20PM
(#12997252)
> What are the reasons behind such prohibitive cost? Rare expertise, advanced factories, amount of time required, lack of economy-of-scale, monopoly, something else?
The first 3. Monopoly doesn't help I'm sure, but this drug class in inherently very expensive to produce, there's a reason there is little outcry over the prices charged.
It's extremely labor intensive, and very hard to scale up. They are also inherently dangerous, so there is a need for extreme purity. (See: https://en.wikipedia.org/wiki/TGN1412 for what a monoclonal antibody can do, you would not want that to happen by accident.)
As of right now this drug class remains the most expensive of all drugs, I would assume if it were possible to make it cheaper they would have.
But we'll only really know once the first generics enter the market.
The first 3. Monopoly doesn't help I'm sure, but this drug class in inherently very expensive to produce, there's a reason there is little outcry over the prices charged.
It's extremely labor intensive, and very hard to scale up. They are also inherently dangerous, so there is a need for extreme purity. (See: https://en.wikipedia.org/wiki/TGN1412 for what a monoclonal antibody can do, you would not want that to happen by accident.)
As of right now this drug class remains the most expensive of all drugs, I would assume if it were possible to make it cheaper they would have.
But we'll only really know once the first generics enter the market.